Assenagon Asset Management
CMD

Assenagon Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Assenagon Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,563
Closed -$947K – 1333
2020
Q3 		$947K Buy
+21,563
New +$1.06M 0.01% 812
2018
Q4 		– Sell
-30,700
Closed -$2.83M – 1205
2018
Q3 		$2.83M Buy
+30,700
New +$2.92M 0.03% 437
2018
Q1 		– Sell
-17,524
Closed -$1.8M – 803
2017
Q4 		$1.8M Buy
+17,524
New +$1.75M 0.02% 454

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Assenagon Asset Management's CMD Position: Q4 2020 in Review

Assenagon Asset Management sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 21,563 shares — an estimated $947K sold.

Assenagon Asset Management first reported a position in CMD in Q4 2017 and held it in 3 quarters. The position peaked at $2.83M in Q3 2018. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Assenagon Asset Management reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
  • Assenagon Asset Management sold 21,563 Cantel Medical Corporation shares in Q4 2020, an estimated $947K.
  • Assenagon Asset Management first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 3 quarters.
  • Assenagon Asset Management's Cantel Medical Corporation position peaked at $2.83M in Q3 2018.
  • 229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Assenagon Asset Management's 13F filing for Q4 2020, filed 1 Feb 2021.